SABCS 2024 Highlights

home / data-dialogue-with-the-oncology-brothers / sabcs-2024-highlights

Panelists discuss key highlights from SABCS 2024, focusing on the latest research, advancements, and emerging trends in breast cancer treatment and care.

EP. 1: INSEMA: No Axillary Surgery vs. Axillary SLNB in Pts With Early Invasive Breast Cancer

Rahul Gosain, MD;Rohit Gosain, MD;Laura Huppert, MD

January 9th 2025

Panelists discuss the INSEMA trial, comparing no axillary surgery versus axillary sentinel lymph node biopsy (SLNB) in patients with early invasive breast cancer, exploring the implications for treatment decisions and patient outcomes.

EP. 2: KEYONTE-522: Exploratory Biomarker Analysis in Periop Pembro vs. Placebo + Chemo

Rahul Gosain, MD;Rohit Gosain, MD;Laura Huppert, MD

January 9th 2025

Panelists discuss the exploratory biomarker analysis from the KEYNOTE-522 trial, comparing perioperative pembrolizumab versus placebo plus chemotherapy in early-stage breast cancer, and its implications for treatment strategies.

EP. 3: OlympiA: Adj Olaparib Post (Neo) Adjuvant Chemo in Pts with Germline BRCA1/BRCA2 & High Risk HER2-negative

Rahul Gosain, MD;Rohit Gosain, MD;Laura Huppert, MD

January 9th 2025

Panelists discuss the OlympiA trial, evaluating adjuvant olaparib post-neoadjuvant chemotherapy in patients with germline BRCA1/BRCA2 mutations and high-risk HER2-negative breast cancer, and its impact on treatment outcomes.

Do Not Sell My Information

Privacy

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777